- Report
- May 2024
- 134 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- June 2024
- 200 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- August 2024
- 250 Pages
Global
From €4734EUR$4,995USD£3,955GBP
- Report
- April 2023
- 115 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- September 2021
- 182 Pages
Global
From €3412EUR$3,600USD£2,851GBP
- Report
- October 2023
- 689 Pages
Global
From €9473EUR$9,995USD£7,914GBP
- Book
- November 2018
- 464 Pages
Optic Neuritis is a medical condition that affects the optic nerve, causing inflammation and vision loss. It is most commonly caused by multiple sclerosis, but can also be caused by other autoimmune diseases, infections, or trauma. Symptoms of optic neuritis include blurred vision, pain with eye movement, and loss of color vision. Treatment typically involves corticosteroids to reduce inflammation and improve vision.
The Optic Neuritis market is composed of companies that develop and market treatments for the condition. These treatments include medications, such as corticosteroids, as well as devices and therapies to improve vision. Companies in the Optic Neuritis market include Novartis, Biogen, and Roche. Show Less Read more